Context: Type 2 diabetes (T2D) and pancreatogenic diabetes are both associated with loss of functional b-cell mass. Previous studies have proposed b-cell dedifferentiation as a mechanism of islet b-cell failure, but its significance in humans is still controversial.
eventually leads to severe dysfunction of insulin secretion (4) . The concept of b-cell dedifferentiation as a key mechanism of b-cell failure was first reported in FoxO1-deficient b-cells. Under metabolic stress, these b-cells became dedifferentiated, reverted to a progenitor-like stage, and partly adopted other endocrine cell fates (5) . Dedifferentiation also occurred in Nkx6.1KO mice (6) , VhlhKO mice (7), neonatal diabetic model KATP-GOF mice (8) , diabetic db/db mice, and diabetic GIRKO mice (9) . Interestingly, insulin treatment not only restored glucose homeostasis in these diabetic mice, but it also reversed the dedifferentiation process (8) . Although evidence of dedifferentiation was also provided in humans, the frequency of hormone-defective dedifferentiated cells in patients with T2D was variable in different studies (10) (11) (12) . It is possible that the variations in blood glucose concentrations of donors might influence the detected ratio of dedifferentiation in the diabetic pancreas graft. To date, the precise mechanisms involved are still not fully understood.
The islet in T2D is characterized by chronic inflammation and a low frequency of ongoing b-cell apoptosis (13, 14) . Proinflammatory cytokines and chemokines likely play a significant role in the pathogenesis of T2D (15) . Recently, Nordmann et al. (16) reported that inflammation triggers b-cell dedifferentiation and dysfunction in vitro; however, whether this mechanism is responsible in vivo is less clear. Chronic pancreatitis (CP) in mice after partial pancreatic duct ligation reduced expression of Pdx1, NeuroD1, Nkx6.1, and MafA (17) . In CP, varying degrees of exocrine inflammation are accompanied by reduced expression of the b-cell-specific transcription factor PDX-1 (18) , and 30% to 50% of patients with CP will eventually become diabetic during disease progression (19) (20) (21) . These results suggest that inflammation plays a role in b-cell failure; however, whether it affects b-cell dedifferentiation in human T2D and pancreatogenic diabetes is far less understood.
The purpose of the current study was to assess b-cell dedifferentiation in patients with T2D with adequate glucose control. As a second question, we sought to investigate the possible involvement of inflammation in b-cell dedifferentiation in patients with T2D and nondiabetic CP (NDCP). Our results demonstrate that there exists a substantial portion of hormone-negative dedifferentiated cells in individuals with T2D with wellcontrolled fasting glucose measured within 1 week before an operation. The number of dedifferentiated cells positively correlates with diabetes duration. Moreover, we found evidence of dedifferentiated cells in patients who were nondiabetic with CP, suggesting that inflammation alone can induce b-cell dedifferentiation, possibly representing a step in the pathogenesis of pancreatogenic diabetes in patients with CP.
Research Design and Methods

Subjects
A total of 2065 cases with partial pancreatectomy performed in the Department of Surgery in Ruijin Hospital between January 2013 and August 2017 were examined. We obtained the pathology diagnosis of each patient and excluded those who had been reported as having a malignant tumor. Fasting blood glucose values were obtained during their routine clinic visit, ;1 week (mean 5.6 6 0.5 days) prior to the operation day (Table 1; Supplemental Table 1 ). According to American Diabetes Association guidelines (22) , preprandial capillary plasma glucose is recommended to be controlled at 4.4 to 7.2 mmol/L for adults who are nonpregnant with diabetes and 5.0 to 8.3 mmol/L for those older adult patients with diabetes and complex health status. By reviewing the medical records and making follow-up, subjects with T2D were selected according to the following criteria: (1) clear diabetes history; (2) fasting blood glucose ,8.3 mmol/L 1 week (mean 5.6 6 0.5 days) prior to operation; and (3) strict glucose self-monitoring and satisfactory capillary glucose control at home. Finally, 10 cases of T2D with adequate glucose control and nine age-and body mass index (BMI)-matched subjects who were nondiabetic were included in the current study, and paraffin sections of their human pancreas far from the margin of pancreatectomy were provided by the Department of Pathology in Ruijin Hospital for subsequent analysis. We also selected four cases of NDCP, and the sections of tissue were identified as having the typical features of CP by pathological diagnosis. All of these tissues were reverified by the pathologist to ensure the final pathology diagnosis. All clinical characteristics of human subjects were obtained during the preoperative examinations and are summarized in Table 1 and Supplemental Table 1 . This study was approved by the Institutional Review Board of the Ruijin Hospital affiliated to Shanghai Jiao-Tong University School of Medicine and was in accordance with the principles of the Declaration of Helsinki II.
Immunohistochemical and morphometric analyses
We fixed and processed tissue for immunohistochemistry as previously described (23) . We performed immunofluorescence assays using 5-mm-thick paraffin sections that were obtained from the Department of Pathology in Ruijin Hospital to detect specific signals in all cases under the same conditions with the standard immunohistochemistry protocol. All slides were treated with tissue antigen recovery to improve the fluorescent immune detection of various proteins. Slides were incubated at 4°C overnight with a cocktail of primary antibodies diluted in the blocking reagent for chromogenic and fluorescence immunohistochemical assays. Primary antibodies were prepared at the following dilutions: guinea pig anti-insulin (1:800, Dako, A056401-2; Glostrup, Denmark), rabbit anti-glucagon (Gcg; 1:200, Abcam, ab10988; Cambridge, MA), rabbit anti-pancreatic polypeptide (Pp; 1:400, EMD Millipore, AB939; Billerica, MA), rabbit anti-somatostatin (Sst; 1:400, EMD Millipore, AB5494), mouse anti-chromogranin A (CGA; 1:100, EMD Millipore, MAB5268), and rabbit anti-Aldh1a3 (1:500, Novus Biologicals, NBP2-15339, Littleton, CO We counted the number of CGA-positive cells with or without endocrine hormones (insulin, Gcg, Pp, and Sst) expression. Those CGA-positive and hormone-negative cells were identified as dedifferentiated cells, and those expressing both insulin and other pancreatic hormones were identified as multihormone cells. All counting was verified by the second researcher in a double-blinded manner.
Histologic study
Paraffin-embedded tissue samples were sliced and stained by hematoxylin and eosin (H&E) to visualize the pathological parameters of pancreatic tissue. Careful scrutiny of pathological features in CP tissues of all cases was performed. The classic features of CP, including inflammatory cell infiltration, atrophy of acinar lobules (atrophy), fibrosis, and steatosis, were assessed according to pathological classification. Two pathologists evaluated the slides double-blinded with unified standards. Degrees of inflammatory cell infiltration, atrophy, fibrosis, and steatosis were evaluated semiquantitatively (Table 2) according to the following scoring system (24) with modifications: 0, absent; 1, a lesion slightly shown in the region of cross-section (foci of lesion occupying ,5% of the tissue area); 2, a lesion widely shown in the region of cross-section (lesion occupying range from 5% to 50% of the tissue area); and 3, a lesion shown across the region of section (severe lesion occupying .50% of the tissue area).
Statistical analysis
All statistical analyses were performed using SPSS version 20.0 statistical software (International Business Machines, Armonk, NY). We used an unpaired Student t test with a All clinical characteristics of human subjects are summarized. Results are presented as mean 6 SEM. An unpaired Student t test (n = 10 in T2D, n = 9 in ND, n = 4 in NDCP) was used for comparisons.
Abbreviations: A, acarbose; BA, biliary adenomyosis; CP, chronic pancreatitis; Gc, gliclazide; Gm, glimepiride; I, insulin; IPMN, intraductal papillary mucinous neoplasm; M, metformin; N/A, not applicable; P, pioglitazone; PMC, pancreatic mucinous cystadenoma; PSM, pancreatic serous microcyst adenoma; PSOA, pancreatic serous oligocystic adenoma; V, voglibose. a T2D case 10 was prescribed with acarbose, but sometimes changed to diet therapy combined with irregular medicine.
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Results
Increased dedifferentiated endocrine cells in islets from patients with T2D with adequate glucose control To evaluate the presence of dedifferentiated cells in normoglycemic patients with T2D, we assessed the number of dedifferentiated cells, that is, islet hormonenegative and CGA-positive (yellow arrows in Fig. 1B ) and multihormone cells containing both insulin and other islet hormone (pink arrows in Fig. 1C ) in pancreas sections from 10 patients with T2D and nine age-and BMI-matched patients who were NDs. Patients with T2D had slightly higher fasting blood glucose levels compared with NDs (6.1 6 0.3 mM vs 5.1 6 0.1 mM, T2D vs ND, P , 0.05, Table 1 ), reaching the glycemic target according to American Diabetes Association guidelines and thus can be considered as under adequate glucose control. In diabetic islets, the ratio of CGA-positive/INS-positive cells declined (56.6% 6 2.0% vs 69.0% 6 2.2%, T2D vs ND, P , 0.001), whereas the endocrine cells expressing Gcg/Pp/Sst rose significantly (37.7% 6 1.9% vs 30.3% 6 2.3%, T2D vs ND, P , 0.05; Fig. 1D ). An almost threefold increase in CGA-positive/hormone-negative dedifferentiated cells was detected in patients with T2D compared with controls (10.0% 6 1.0% vs 3.6% 6 0.3%, T2D vs ND, P , 0.0001; Fig. 1E ; Table 2 ). Additionally, multihormone cells coexpressing insulin and Gcg/Pp/Sst were increased significantly in T2D (4.2% 6 0.4% vs 2.8% 6 0.5%, T2D vs ND, P , 0.05; Fig. 1E ; Table 2 ). These data suggest that the deficit of b-cell numbers in diabetic islets is at least partly attributed to loss of cell identify of the dedifferentiated cells. Additionally, the patients with diabetes in the current study have all reached the glycemic targets before operation, reinforcing that the dedifferentiation process persistently occurred in subjects with T2D with adequate glucose control.
Disease duration, but not age and BMI, is correlated with the frequency of dedifferentiated cells
We then sought to assess the clinical parameters that may be associated with CGA-positive/hormone-negative dedifferentiated cells. To this end, we performed a correlation analysis in the diabetic cohort between the percentage of dedifferentiated cells and patients' age, BMI, or duration of diabetes. We found that the percentage of dedifferentiated cells was positively correlated with the duration of diabetes (r 2 = 0.578, P = 0.028; Fig. 2B ). In contrast, there was no statistically significant relationship between the percentage of dedifferentiated cells and age or BMI ( Fig. 2C and 2D ). We also found that the percentage of multihormone cells was significantly correlated with the duration of diabetes The ratios of dedifferentiated cells and multihormone cells were determined. All data are expressed as mean 6 SEM. An unpaired Student t test was performed between the two groups (n = 10 in the T2D group, n = 9 in the ND group). *P , 0.05, ***P , 0.001.
(r 2 = 0.703, P = 0.009; Fig. 2E ), but not with age or BMI ( Fig. 2F and 2G ). We noticed that there exists interislet heterogeneity in dedifferentiated cells within the same patient (Supplemental Fig. 1 ). The dedifferentiated cells were frequently located in islets that had lost their normal structures (no. 2 islet, Supplemental Fig. 1 ), whereas the "healthy" islets from the same patient had few such "empty" cells (no. 1 islet, Supplemental Fig. 1 ). We could also detect sporadic single CGA-positive/hormone-negative cells in islets with irregular morphology (no. 3 islet, Supplemental Fig. 1) . That dedifferentiated cells are more frequently observed in ill-appearing islets led us to evaluate pathological changes in nondiabetic and diabetic pancreas. We performed H&E staining on paraffin slices of individual pancreas and scored their pathological parameters, including inflammation, fibrosis, atrophy, and steatosis in each case ( Fig. 3A-3D ; Table 2 ). There was almost no inflammatory cell infiltration, fibrosis, atrophy, and steatosis in any case of the ND group ( Fig. 3A and 3B ; Table 2 ). Some cases of T2D (three out of eight) exhibited minor inflammatory cells scattered throughout the pancreas and localized fibrous tissue near diabetic islets ( Fig. 3C and 3D ; Table 2 ). However, no statistical differences were detected in the grade of inflammation, fibrosis, atrophy, and steatosis between the ND and T2D group (Fig. 3G) . No correlation between the percentage of dedifferentiated cells and the grade of inflammation could be found in the diabetic cohort.
Increased dedifferentiated islet cells in patients who were nondiabetic with CP
To examine whether severe inflammation could exert a direct effect on human b-cell dedifferentiation, we obtained pancreas from four subjects who were nondiabetic with CP (NDCP) and calculated the percentage of dedifferentiated cells and multihormone-positive cells (Fig. 4) . H&E staining was used to evaluate the pathological characteristics of CP, including infiltration, fibrosis, and atrophy in SEM. An unpaired Student t test was used for three groups (n = 10 in T2D, n = 9 in ND, n = 4 in NDCP). **P , 0.01, ***P , 0.001. Immunofluorescence staining was performed to detect Aldh1a3 (red), insulin (green) and DAPI (blue) in islets in ND, T2D, and NDCP cases, respectively, and representative images of islets from three groups are shown. Scale bars, 20 mm. For (C) and (D), an unpaired Student t test for two groups and a rank sum test for ranked ordinal data were performed. Results are presented as mean 6 SEM. Correlations are presented as Spearman r. ***P , 0.001. these cases (Fig. 3) . We could clearly observe abnormal pathological changes, including obvious inflammatory infiltration, evident fibrosis, and different degrees of atrophy and steatosis near the islets in NDCP ( Fig. 3E and  3F ; Table 2 ). We found statistically significant differences in the grade of inflammation, fibrosis, and atrophy between the NDCP group and the ND/T2D group (Fig. 3G) .
Interestingly, in these nondiabetic islets, we observed a significant number of CGA-positive/hormone-negative cells that constituted empty regions in the islet (Fig. 4A and 4B) . Indeed, the calculation showed a remarkable increase in the percentage of dedifferentiated cells in the NDCP group compared with the ND group (10.4% 6 0.9% vs 3.6% 6 0.3%, NDCP vs ND, P , 0.0001; Fig. 4C ; Table 2 ). On the contrary, the percentage of multihormone cells remained unchanged in the NDCP group (3.2% 6 0.5% vs 2.8% 6 0.5%, NDCP vs ND, P = not significant; Table 2 ). We then performed a TUNEL assay to evaluate apoptosis in pancreas from NDCP cases. We did not find evidence of increased apoptosis in endocrine cells of patients with NDCP: no TUNEL-positive cells were observed in islets and only a very limited number of TUNEL-positive cells were scattered in exocrine gland (Supplemental Fig. 2) . We next assessed the correlation between the percentage of dedifferentiated cells and the pathological parameters in the ND and NDCP groups using a rank sum test (Fig. 4D) . A strong positive correlation was found between the percentage of dedifferentiated cells and the degree of inflammation (r = 0.836, P , 0.01; Fig. 4D ), fibrosis (r = 0.777, P , 0.01; Fig. 4D ), and atrophy (r = 0.815, P , 0.01; Fig. 4D ). In contrast, no significant correlation was found between the percentage of multihormone cells and any of these pathological parameters (Fig. 4D) . These results suggest that chronic inflammation can trigger b-cell dedifferentiation in the nondiabetic human islet.
Recently, Aldh1a3 has been proposed as a novel marker of dedifferentiated b-cells in murine and human islets (6, 10, (25) (26) (27) . We performed immunohistochemical staining against Aldh1a3 in pancreas slices in ND, T2D, and NDCP cases. Consistent with the previous observations (10), we could hardly detect Aldh1a3 staining in NDs, but found substantial Aldh1a3-positive cells in diabetic islets (Fig. 4E) . Interestingly, we reported, to our knowledge for the first time, that Aldh1a3 was abundantly expressed in the islet of NDCP (Fig. 4E) . In combination, our results are conclusive that pancreatic b-cells are dedifferentiated not only in patients with T2D with adequate glucose control, but also in patients with NDCP.
Discussion
Functional b-cell mass is determined not only by the number of b-cells, but also by their functional maturation and differentiation state (28) . Growing evidence suggests that under certain metabolic stress, mature b-cells can lose their identity and mature/differentiated phenotype and regress to a precursor-like dedifferentiated state (5). b-Cell dedifferentiation involves: (1) loss of genes critical for b-cell identity and maturity, (2) ectopic expression of genes that are disallowed in b-cells, and (3) acquisition of a progenitor-like phenotype and reconfiguration potency (29) . This concept has been implicated in the pathogenesis of diabetes. However, to gain therapeutic relevance it needs to be demonstrated in human T2D islets. Some promising observations in human T2D have been reported. Cinti et al. (10) reported that dedifferentiated cells accounted for 16.8% in T2D vs 6.5% in controls of all pancreatic endocrine cells, and these dedifferentiated cells convert to a-like and d-like cells. Additionally, human diabetic islets had more frequency of multihormone-expression cells (30, 31) with relatively poor glucose sensitivity (32) . These "mixed phenotype" cells are consistent with the loss of b-cell identity and acquire a-cell characteristics in T2D islets. Whereas the aforementioned results indicate that dedifferentiation plays an important role in human T2D, other studies argued that dedifferentiation is minimal in lean and obese T2D and posited hormone-negative/CGA-positive cells as immature b-cells arising during regeneration (11, 12) . In consideration of controversy in the field, we determined to provide data on b-cell dedifferentiation in a Chinese T2D cohort with adequate glucose control. Our data demonstrate a substantial portion of dedifferentiated endocrine cells (;10.0%) in patients with T2D, even when they have reached the glycemic targets for at least 1 week in duration. A nearly threefold increase in hormone-negative dedifferentiated cells coincides with a significant decline in INS-positive endocrine cells in diabetic islets, indicating that dedifferentiation may contribute to b-cell loss in T2D. We observed interislet heterogeneity in the degree of dedifferentiation in the same subject. The dedifferentiated cells more frequently resided in islets with abnormal structures, but very few resided in the intact islet. Single dedifferentiated cells could also be found interspersed in pancreas adjoining big islets in T2D. Additionally, we found increases not only in endocrine cells expressing Gcg/Pp/Sst, but also in multihormone cells in human T2D islets. The frequencies of dedifferentiated and multihormone cells were positively correlated with disease duration of T2D: the dedifferentiation ratios of three subjects with .15 years diabetic history are all .12%. Collectively, our data provide evidence for dedifferentiation of islet b-cells in T2D with adequate glycemic control.
The mechanisms implicated in b-cell dedifferentiation include oxidative stress (33-37), endoplasmic reticulum stress (38) (39) (40) (41) (42) (43) , inflammation (16) , and hypoxia (7, 44, 45) . Among these, inflammation of the pancreas has been suggested to be associated with the pathogenesis of diabetes mellitus. Pancreatogenic diabetes mellitus, also referred to as type 3c diabetes, can be caused by exocrine pancreatic diseases, including CP (46) . The key mechanism underlying the high risk of diabetes in CP was the deficiency in insulin production (46) and the reduced expression of PDX1 (18) . It has been reported that b-cell dedifferentiation and dysfunction can be triggered by inflammation in vitro, but whether it is essential in vivo is still unclear (16, 47) . In the current study, we found a significant increase in dedifferentiated cells in NDCP (;10.4%) compared with normal controls (;3.6%). Remarkably, besides sporadic single nonhormoneexpressing endocrine cells, we detected most dedifferentiated cells located in the islet, forming nonhormone empty regions. We also detected an increased expression of Aldh1a3, a novel marker of dedifferentiated b-cells (10) in both NDCP and T2D. We did not find evidence for b-cell apoptosis in NDCP islets; however, the percentage of dedifferentiated cells was positively correlated with the grade of infiltration, fibrosis, and atrophy in the pancreas tissue from nondiabetic CP and controls, indicating a direct role of exocrine inflammation on b-cell dedifferentiation. In the current study, the percentage of dedifferentiated cells in nondiabetic CP is even higher than that in T2D, indicating that the dedifferentiation process may contribute to pancreatogenic diabetes during disease progression of CP. Indeed, diabetes is a frequent comorbidity of CP, with prevalence estimates ranging from 25% to 80% (47) (48) (49) (50) (51) . Increased disease duration is an important risk factor for diabetes secondary to CP (51) . Several lines of evidence support the involvement of the islet inflammatory process in the pathophysiological derangements in T2D (47) . Although in human diabetes, we did not detect correlation between the ratio of dedifferentiated cells and the degree of infiltration, we cannot rule out a possible role of inflammation in T2D, because microinflammation in the process of T2D cannot be evaluated by H&E staining. More efforts are needed to characterize the possible roles of inflammatory mediators, such as interleukins, cytokines, and chemokines, on b-cell dedifferentiation in human diabetic islets.
Nevertheless, we point out the limitations of the current study. First, our preliminary results are from a relatively small cohort, and therefore our conclusions need to be confirmed in larger, prospective studies. Second, owing to the limitation of retrospective studies, we were unable to collect more glycemic values, such as the stable glycemic indicator HbA1c level. Third, we could not exclude the possibility that those "dedifferentiated cells" may still contain very low levels of hormone expression, which are undetectable by current immunofluorescence technology or they still have proinsulin but no longer express insulin (52) . Well-designed delicate perspective studies combined with more sensitive detection techniques are required to verify those dedifferentiated cells in future studies.
In summary, we demonstrate that the percentage of dedifferentiated b-cells is remarkably increased in patients with NDCP and patients with T2D with adequate glucose control. Furthermore, our findings reveal that exocrine inflammation might drive pancreatic islet b-cell loss of differentiation and eventually lead to b-cell failure. We provide an underlying mechanism for type 3c diabetes; however, the role of inflammatory response within islets in T2D on b-cell dedifferentiation remains to be explored.
